Jane Ensey
Family Medicine · Colleyville, TXNPI 1871536672
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 92 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 14.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $689 and has fallen 91.0% since, to $62 in 2023.
Across 92 payments — averaging $14.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$197
- Lilly USA, LLC$142
- AbbVie$94
- Abbott$91
- Boehringer Ingelheim$91
- Novo Nordisk$79
- plus $683 from 24 others
What the payments were for
- Food & beverage$1,377100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 13 | $197 |
| Lilly USA, LLC | 12 | $142 |
| AbbVie(2 entities) | 7 | $94 |
| Abbott | 6 | $91 |
| Boehringer Ingelheim | 4 | $91 |
| Novo Nordisk | 5 | $79 |
| Johnson & Johnson | 2 | $78 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $66 |
| Novartis | 5 | $62 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $51 |
| Althera Pharmaceuticals LLC | 3 | $43 |
| Amarin Pharma, Inc. | 3 | $43 |
| AstraZeneca | 3 | $38 |
| Merck | 3 | $38 |
| Astellas Pharma US Inc | 2 | $32 |
| Arbor Pharmaceuticals, Inc. | 2 | $25 |
| Sobi, Inc | 1 | $23 |
| Sanofi-aventis U.S. LLC | 1 | $20 |
| Inspire Medical Systems, Inc. | 1 | $19 |
| Biohaven Pharmaceuticals, Inc. | 1 | $17 |
| Therapeuticsmd, Inc. | 1 | $15 |
| Adlon Therapeutics L.p. | 1 | $14 |
| Genentech USA, Inc. | 1 | $13 |
| Alnylam Pharmaceuticals Inc. | 1 | $13 |
| Currax Pharmaceuticals LLC | 1 | $13 |
| Idorsia Pharmaceuticals US Inc | 1 | $13 |
| Amgen | 1 | $12 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
| Eisai Inc. | 1 | $12 |
| Ironwood Pharmaceuticals, Inc | 1 | $11 |
How this compares
$1,377 in reported general payments places this provider in the 65th percentile of 8,760 family medicine providers in Texas.
Other family medicine in Colleyville
- Carlos CamposNew Braunfels$1.5M
- Aaron KingSan Antonio$1.1M
- Bradley WassonArlington$734K
- Cynthia BrinsonAustin$402K
- Michael MendezLubbock$368K
- Sang Tae KimAmarillo$368K
- Sumit PerakathuHarlingen$342K
- Joel SolisMcAllen$324K
- Robert CampbellFort Worth$318K
- Jose LedezmaEdinburg$300K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.